Galera therapeutics reports third quarter 2020 financial results and provides business updates

Presented promising interim data from placebo-controlled p ilot dismutase mimetic sbrt combination trial for p ancreatic c ancer
GRTX Ratings Summary
GRTX Quant Ranking